Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06885021 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluate the Safety and Efficacy of HDM1002 Tablets in Chinese Overweight and Obese Adults

StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 19, 2025 (before its estimated May 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
A Phase 3 Trial to Evaluate the Safety and Efficacy of HDM1002 Tablets in Overweight and Obese Adults
Trial Details
NCT Number NCT06885021
Lead Sponsor Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Conditions
(from sponsor)		 Overweight and Obesity
Related terms Obesity, Overweight
Enrollment 780 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov